Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Taipei
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

InnoPharmax Inc

+ Add to Watchlist

4172:TT

28.05 TWD 0.45 1.58%

As of 01:24:30 ET on 05/27/2015.

Snapshot for InnoPharmax Inc (4172)

Open: 28.50 Day's Range: 27.17 - 28.50 Volume: 163,000
Previous Close: 28.50 52wk Range: 27.17 - 82.49 1-Yr Rtn: -63.81%

Stock Chart for 4172

No chart data available.
  • 4172:TT 28.15
  • 1D
  • 1M
  • 1Y
28.50
Interactive 4172 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4172

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 28.3333
Relative P/E vs. TWOTCI -
Earnings Per Share (TWD) (ttm) -
Est. EPS (TWD) (12/2015) 0.9900
Est. PEG Ratio -
Market Cap (M TWD) 1,488.33
Shares Outstanding (M) 53.06
30 Day Average Volume 88,938
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/21/2016
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4172

No data available

Company Profile & Key Executives for 4172

InnoPharmax Inc. is a specialty pharmaceutical company. The Company develops and commercializes products for the treatment of infectious diseases, immunology, and oncology.

Lin Chih-HuiChairmanHsu Chang-ShanPresident
Hao Wei-HuaVP/Chief R & D OfficerTsai Pei-JungDirector:Finance
More Company Profile & Key Executives for 4172

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil